H. Jick, G. Zornberg, S. Jick, S. Seshadri, and D. Drachman, Statins and the risk of dementia, The Lancet, vol.356, issue.9242, pp.1627-1631, 2000.
DOI : 10.1016/S0140-6736(00)03155-X

B. Wolozin, W. Kellman, P. Ruosseau, G. Celesia, and G. Siegel, Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors, Archives of Neurology, vol.57, issue.10, pp.1439-1443, 2000.
DOI : 10.1001/archneur.57.10.1439

S. Locatelli, D. Lutjohann, and H. Schmidt, Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia, Archives of Neurology, vol.59, issue.2, pp.213-216, 2002.
DOI : 10.1001/archneur.59.2.213

E. Rodriguez, H. Dodge, M. Birzescu, G. Stoehr, and M. Ganguli, Use of Lipid-Lowering Drugs in Older Adults With and Without Dementia: A Community-Based Epidemiological Study, Journal of the American Geriatrics Society, vol.122, issue.11, pp.1852-1856, 2002.
DOI : 10.1046/j.1532-5415.2002.50515.x

K. Yaffe, E. Barrett-connor, F. Lin, and D. Grady, Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women, Archives of Neurology, vol.59, issue.3, pp.378-384, 2002.
DOI : 10.1001/archneur.59.3.378

J. Shepherd, G. Blauw, and M. Murphy, Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial, The Lancet, vol.360, issue.9346, pp.1623-1630, 2002.
DOI : 10.1016/S0140-6736(02)11600-X

A. Hofman, A. Ott, and M. Breteler, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study, The Lancet, vol.349, issue.9046, pp.151-154, 1997.
DOI : 10.1016/S0140-6736(96)09328-2

A. Aupérin, C. Berr, and C. Bonithon-kopp, Ultrasonographic Assessment of Carotid Wall Characteristics and Cognitive Functions in a Community Sample of 59- to 71-Year-Olds, Stroke, vol.27, issue.8, pp.1290-1295, 1996.
DOI : 10.1161/01.STR.27.8.1290

D. Carmelli, G. Swan, and T. Reed, Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins, Neurology, vol.50, issue.6, pp.1580-1585, 1998.
DOI : 10.1212/WNL.50.6.1580

E. Frears, D. Stephens, C. Walters, H. Davies, and A. Bm, The role of cholesterol in the biosynthesis of ??-amyloid., NeuroReport, vol.10, issue.8, pp.1699-1705, 1999.
DOI : 10.1097/00001756-199906030-00014

K. Fassbender, M. Simons, and C. Bergmann, Simvastatin strongly reduces levels of Alzheimer's disease ??-amyloid peptides A??42 and A??40 in vitro and in vivo, Proceedings of the National Academy of Sciences, vol.98, issue.10, pp.5856-5861, 2001.
DOI : 10.1073/pnas.081620098

I. Notkola, R. Sulkava, and J. Pekkanen, Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer???s Disease, Neuroepidemiology, vol.17, issue.1, pp.14-20, 1998.
DOI : 10.1159/000026149

Z. Tan, S. Seshadri, and A. Beiser, Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease, Archives of Internal Medicine, vol.163, issue.9, pp.1053-1057, 2003.
DOI : 10.1001/archinte.163.9.1053

R. Evans, C. Emsley, and S. Gao, Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans, Neurology, vol.54, issue.1, pp.240-242, 2000.
DOI : 10.1212/WNL.54.1.240

S. Romas, M. Tang, L. Berglund, and R. Mayeux, APOE genotype, plasma lipids, lipoproteins, and AD in community elderly, Neurology, vol.53, issue.3, pp.517-521, 1999.
DOI : 10.1212/WNL.53.3.517

M. Pappolla, T. Bryant-thomas, and D. Herbert, Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology, Neurology, vol.61, issue.2, pp.199-205, 2003.
DOI : 10.1212/01.WNL.0000070182.02537.84

M. Kivipelto, E. Helkala, and M. Laakso, Apolipoprotein E ??4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease, Annals of Internal Medicine, vol.137, issue.3, pp.149-155, 2002.
DOI : 10.7326/0003-4819-137-3-200208060-00006

G. Jarvik, E. Wijsman, and W. Kukull, Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study, Neurology, vol.45, issue.6, pp.1092-1096, 1995.
DOI : 10.1212/WNL.45.6.1092

J. Dietschy and S. Turley, Cholesterol metabolism in the brain, Current Opinion in Lipidology, vol.12, issue.2, pp.105-112, 2001.
DOI : 10.1097/00041433-200104000-00003

S. Reilly, R. Ferrell, B. Kottke, M. Kamboh, and C. Sing, The genderspecific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I Pleiotropic effects on means and variances, Am J Hum Genet, vol.49, pp.1155-1166, 1991.

E. Corder, A. Saunders, and W. Strittmatter, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, issue.5123, pp.921-923, 1993.
DOI : 10.1126/science.8346443

C. Kirsch, G. Eckert, A. Koudinov, and W. Muller, Brain cholesterol, statins and Alzheimer's disease, Pharmacopsychiatry, vol.36, pp.113-119, 2003.

3. Study and G. , Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

W. Koch, A. Ehrenhaft, and K. Griesser, TaqMan Systems for Genotyping of Disease-Related Polymorphisms Present in the Gene Encoding Apolipoprotein E, Clinical Chemistry and Laboratory Medicine, vol.40, issue.11, pp.1123-1131, 2002.
DOI : 10.1515/cclm.2002.197

J. Saxton, G. Ratcliff, and A. Newman, Cognitive Test Performance and Presence of Subclinical Cardiovascular Disease in the Cardiovascular Health Study, Neuroepidemiology, vol.19, issue.6, pp.312-319, 2000.
DOI : 10.1159/000026270

D. Commenges, M. Gagnon, L. Letenneur, J. Dartigues, P. Barbergergateau et al., Improving Screening for Dementia in the Elderly Using Mini-Mental State Examination Subscores, Benton??s Visual Retention Test, and Isaacs?? Set Test, Epidemiology, vol.3, issue.2, pp.185-188, 1992.
DOI : 10.1097/00001648-199203000-00019

L. Radloff, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Applied Psychological Measurement, vol.1, issue.3, pp.385-401, 1977.
DOI : 10.1177/014662167700100306

R. Fuhrer and F. Rouillon, La version francaise de l'echelle CES-D, Psychiatr Psychobiol, vol.4, pp.163-166, 1989.

K. Rockwood, S. Kirkland, and D. Hogan, Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People, Archives of Neurology, vol.59, issue.2, pp.223-227, 2002.
DOI : 10.1001/archneur.59.2.223

I. Skoog, The relationship between blood pressure and dementia: a review, Biomedicine & Pharmacotherapy, vol.51, issue.9, pp.367-375, 1997.
DOI : 10.1016/S0753-3322(97)89428-0

F. Forette, M. Seux, and J. Staessen, The Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>, Archives of Internal Medicine, vol.162, issue.18, pp.2046-2052, 2002.
DOI : 10.1001/archinte.162.18.2046

C. Reitz, M. Tang, J. Luchsinger, and R. Mayeux, Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia, Archives of Neurology, vol.61, issue.5, pp.705-714, 2004.
DOI : 10.1001/archneur.61.5.705

C. Vaughan, M. Murphy, and B. Buckley, Statins do more than just lower cholesterol, The Lancet, vol.348, issue.9034, p.214, 1997.
DOI : 10.1016/S0140-6736(96)05190-2

M. Crisby, L. Carlson, and B. Winblad, Statins in the Prevention and Treatment of Alzheimer Disease, Alzheimer Disease & Associated Disorders, vol.16, issue.3, pp.131-136, 2002.
DOI : 10.1097/00002093-200207000-00001

S. Petanceska, S. Derosa, and V. Olm, Statin therapy for Alzheimer???s disease, Journal of Molecular Neuroscience, vol.98, issue.1-2, pp.155-161, 2002.
DOI : 10.1007/s12031-002-0026-2

D. Champagne, D. Pearson, D. Dea, J. Rochford, and J. Poirier, The cholesterol-lowering drug Probucol increases apolipoprotein e production in the hippocampus of aged rats: implications for Alzheimer???s disease, Neuroscience, vol.121, issue.1, pp.99-110, 2003.
DOI : 10.1016/S0306-4522(03)00361-0

C. Geroldi, L. Ferrucci, and S. Bandinelli, Mild Cognitive Deterioration with Subcortical Features: Prevalence, Clinical Characteristics, and Association with Cardiovascular Risk Factors in Community-Dwelling Older Persons (The InCHIANTI Study), Journal of the American Geriatrics Society, vol.16, issue.8, pp.1064-1071, 2003.
DOI : 10.1046/j.1532-5415.2003.51353.x

W. Gibson, G. Eckert, U. Igbavboa, and W. Muller, Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1610, issue.2, pp.281-290, 2003.
DOI : 10.1016/S0005-2736(03)00025-7

S. Dewilde, I. Carey, and S. Bremner, Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?, Heart, vol.89, issue.4, pp.417-421, 1994.
DOI : 10.1136/heart.89.4.417